CMC & scale-up primer
Early-discovery through preclinical bridging topics—host comparability, method transfers and change-control windows; catalogue goods emphasize release consistency while bespoke programs follow scoped TS assessments.
Comparability & changes
Vector upgrades or purification tweaks may shift release thresholds—communicated via change notices or batch documentation.
Bridge scale-up lots with a cohesive analytical panel—endotoxin, purity and binding readouts. Reference-range updates must sync with QA and COA wording.
Method transfer cues
Representative SDS-PAGE / SEC panels illustrate catalogue lots—repeat matrix/pre-processing validation when inheriting internally.
Host comparability & glycosylation
HEK293 / CHO, insect and E. coli routes diverge in glycosylation, folding and fragmentation risk—catalogue SKUs suit discovery; escalate host + release bundles early for regulated paths.
Documentation bundles
Application notes and whitepapers capture platform rationales—read alongside lot COAs and IFUs; bespoke programs scope study reports and change windows separately.